Clinical trial
A Randomized-Controlled Trial of Semaglutide for Patients With Chronic Low Back Pain and Obesity
NCT07731256 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized-Controlled Trial of Semaglutide for Patients With Chronic Low Back Pain and Obesity
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- February 1, 2027
- Completion date
- September 1, 2031
- Enrollment
- 250 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chronic lower back pain, glp1 agonist, lower back pain, obesity (bmi>30)